| Effectiveness and safety of apixaban versus rivaroxaban for prevention of recurrent venous thromboembolism and adverse bleeding events in patients with venous thromboembolism … GK Dawwas, J Brown, E Dietrich, H Park The Lancet Haematology 6 (1), e20-e28, 2019 | 90 | 2019 |
| Nonalcoholic fatty liver disease increases risk of incident advanced chronic kidney disease: a propensity‐matched cohort study H Park, GK Dawwas, X Liu, MH Nguyen Journal of internal medicine 286 (6), 711-722, 2019 | 76 | 2019 |
| Cardiovascular outcomes of sodium glucose cotransporter‐2 inhibitors in patients with type 2 diabetes GK Dawwas, SM Smith, H Park Diabetes, Obesity and Metabolism 21 (1), 28-36, 2019 | 72 | 2019 |
| Risk for recurrent venous thromboembolism and bleeding with apixaban compared with rivaroxaban: an analysis of real-world data GK Dawwas, CE Leonard, JD Lewis, A Cuker Annals of internal medicine 175 (1), 20-28, 2022 | 37 | 2022 |
| Effectiveness and safety of direct oral anticoagulants versus warfarin in patients with valvular atrial fibrillation: a population-based cohort study GK Dawwas, E Dietrich, A Cuker, GD Barnes, CE Leonard, JD Lewis Annals of internal medicine 174 (7), 910-919, 2021 | 31 | 2021 |
| Incidence, prevalence, and racial and ethnic distribution of inflammatory bowel disease in the United States JD Lewis, LE Parlett, MLJ Funk, C Brensinger, V Pate, Q Wu, GK Dawwas, ... Gastroenterology 165 (5), 1197-1205. e2, 2023 | 30 | 2023 |
| Screening to identify signals of opioid drug interactions leading to unintentional traumatic injury CE Leonard, CM Brensinger, TPP Nguyen, JR Horn, S Chung, WB Bilker, ... Biomedicine & Pharmacotherapy 130, 110531, 2020 | 20 | 2020 |
| The risk of sudden cardiac arrest and ventricular arrhythmia with rosiglitazone versus pioglitazone: real-world evidence on thiazolidinedione safety CL Leonard, C.E., Brensinger, C.M., Dawwas, G.K., Deo, R., Bilker, W.B ... Cardiovascular Diabetology 19 (1), 1-11, 2020 | 19 | 2020 |
| Risk of heart failure hospitalization among users of dipeptidyl peptidase-4 inhibitors compared to glucagon-like peptide-1 receptor agonists GK Dawwas, SM Smith, H Park Cardiovascular diabetology 17, 1-9, 2018 | 19 | 2018 |
| Comparative effectiveness and safety of apixaban versus warfarin in patients with venous thromboembolism GK Dawwas, SM Smith, E Dietrich, WH Lo-Ciganic, H Park American Journal of Health-System Pharmacy 77 (3), 188-195, 2020 | 18 | 2020 |
| Prevalence and factors associated with fecal urgency among patients with ulcerative colitis and Crohn’s disease in the study of a prospective adult research cohort with … GK Dawwas, H Jajeh, M Shan, AN Naegeli, T Hunter, JD Lewis Crohn's & Colitis 360 3 (3), otab046, 2021 | 16 | 2021 |
| Comparative effectiveness and safety of ticagrelor versus prasugrel in patients with acute coronary syndrome: a retrospective cohort analysis GK Dawwas, E Dietrich, DE Winchester, AG Winterstein, R Segal, H Park Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 39 (9 …, 2019 | 15 | 2019 |
| Long-term outcomes following multiply recurrent clostridioides difficile infection and fecal microbiota transplantation GK Dawwas, CM Brensinger, RK Vajravelu, Q Wu, CR Kelly, L Laine, ... Clinical Gastroenterology and Hepatology 20 (4), 806-816. e6, 2022 | 14 | 2022 |
| Comparative safety of sodium–glucose cotransporter 2 inhibitors versus dipeptidyl peptidase 4 inhibitors and sulfonylureas on the risk of diabetic ketoacidosis GK Dawwas, JH Flory, S Hennessy, CE Leonard, JD Lewis Diabetes Care 45 (4), 919-927, 2022 | 12 | 2022 |
| Risk of sudden cardiac arrest and ventricular arrhythmia with sulfonylureas: an experience with conceptual replication in two independent populations N Dhopeshwarkar, CM Brensinger, WB Bilker, SE Soprano, JH Flory, ... Scientific Reports 10 (1), 10070, 2020 | 12 | 2020 |
| Real-world evidence comparing vedolizumab and ustekinumab in antitumor necrosis factor-experienced patients with Crohn's disease MD Kappelman, S Adimadhyam, L Hou, AE Wolfe, S Smith, AL Simon, ... Official journal of the American College of Gastroenterology| ACG 118 (4 …, 2023 | 11 | 2023 |
| Apixaban versus rivaroxaban in patients with atrial fibrillation and valvular heart disease: a population-based study GK Dawwas, A Cuker, GD Barnes, JD Lewis, S Hennessy Annals of internal medicine 175 (11), 1506-1514, 2022 | 10 | 2022 |
| Population‐based signals of antidepressant drug interactions associated with unintentional traumatic injury CE Leonard, CM Brensinger, EK Acton, TA Miano, GK Dawwas, JR Horn, ... Clinical Pharmacology & Therapeutics 110 (2), 409-423, 2021 | 6 | 2021 |
| Identifying clinically relevant drug–drug interactions with methadone and buprenorphine: a translational approach to signal detection TA Miano, L Wang, CE Leonard, CM Brensinger, EK Acton, GK Dawwas, ... Clinical Pharmacology & Therapeutics 112 (5), 1120-1129, 2022 | 5 | 2022 |
| Skeletal muscle relaxant drug–drug–drug interactions and unintentional traumatic injury: Screening to detect three‐way drug interaction signals C Chen, S Hennessy, CM Brensinger, GK Dawwas, EK Acton, WB Bilker, ... British journal of clinical pharmacology 88 (11), 4773-4783, 2022 | 5 | 2022 |
